GlassScriptPhysician profile
Lora Ann Raines
NPI 1992198980
$2,198.89
in general payments reported to CMS, 2019-2025
16 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $406 · 2023: $584 · 2024: $456 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.07 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $656.82 | 2021-2025 | Aveir, Ensite, Cardiomems |
| Janssen Pharmaceuticals, INC | $268.36 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.20 | 2023-2025 | Lifevest |
| Atricure, INC. | $168.86 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Edwards Lifesciences Corporation | $157.31 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Biotronik INC. | $128.74 | 2021 | |
| Kestra Medical Technology Services, INC. | $95.92 | 2024-2025 | Assure Wcd |
| Medtronic, INC. | $89.12 | 2021-2024 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $83.76 | 2023-2024 | |
| Pfizer INC. | $83.61 | 2023 | |
| Ebr Systems, INC. | $81.49 | 2025 | |
| Boston Scientific Corporation | $50.73 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $44.48 | 2022-2025 | Eliquis |
| Actelion Pharmaceuticals US, INC. | $21.01 | 2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $20.09 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.39 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Raines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.